DK2800809T3 - PROTEASE-DEFECTED FILAMENTARY FUNGAL CELLS AND PROCEDURES FOR USE THEREOF - Google Patents

PROTEASE-DEFECTED FILAMENTARY FUNGAL CELLS AND PROCEDURES FOR USE THEREOF Download PDF

Info

Publication number
DK2800809T3
DK2800809T3 DK13700021.2T DK13700021T DK2800809T3 DK 2800809 T3 DK2800809 T3 DK 2800809T3 DK 13700021 T DK13700021 T DK 13700021T DK 2800809 T3 DK2800809 T3 DK 2800809T3
Authority
DK
Denmark
Prior art keywords
seq
protease
proteases
cell
trichoderma
Prior art date
Application number
DK13700021.2T
Other languages
Danish (da)
English (en)
Inventor
Christopher Landowski
Anne Huuskonen
Juhani Saarinen
Ann Westerholm-Parvinen
Anne Kanerva
Jari Natunen
Anna-Liisa Hänninen
Noora Salovuori
Merja Penttilä
Markku Saloheimo
Original Assignee
Glykos Finland Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47520118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2800809(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glykos Finland Oy filed Critical Glykos Finland Oy
Application granted granted Critical
Publication of DK2800809T3 publication Critical patent/DK2800809T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK13700021.2T 2012-01-05 2013-01-04 PROTEASE-DEFECTED FILAMENTARY FUNGAL CELLS AND PROCEDURES FOR USE THEREOF DK2800809T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261583559P 2012-01-05 2012-01-05
PCT/EP2013/050126 WO2013102674A2 (en) 2012-01-05 2013-01-04 Protease deficient filamentous fungal cells and methods of use thereof

Publications (1)

Publication Number Publication Date
DK2800809T3 true DK2800809T3 (en) 2018-05-22

Family

ID=47520118

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13700021.2T DK2800809T3 (en) 2012-01-05 2013-01-04 PROTEASE-DEFECTED FILAMENTARY FUNGAL CELLS AND PROCEDURES FOR USE THEREOF

Country Status (14)

Country Link
US (5) US9567596B2 (enExample)
EP (2) EP2800809B1 (enExample)
JP (2) JP6245528B2 (enExample)
KR (1) KR20140114860A (enExample)
CN (2) CN107868758A (enExample)
AU (1) AU2013207165B2 (enExample)
BR (1) BR112014016587A2 (enExample)
CA (1) CA2861697C (enExample)
DK (1) DK2800809T3 (enExample)
IL (1) IL233052A0 (enExample)
MX (1) MX355226B (enExample)
RU (1) RU2645252C2 (enExample)
SG (1) SG11201403818XA (enExample)
WO (1) WO2013102674A2 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014016587A2 (pt) * 2012-01-05 2020-10-27 Novartis Ag células fúngicas filamentosas deficientes de protease e métodos de uso das mesmas
CA2906671A1 (en) * 2013-03-14 2014-09-25 Glycobia, Inc. Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes
DK3019602T3 (en) 2013-07-10 2018-11-12 Glykos Finland Oy MULTIPLE PROTEASE-DEFECTED FILAMENTARY FUNGAL CELLS AND PROCEDURES FOR USE THEREOF
CA2954974A1 (en) * 2014-07-21 2016-01-28 Glykos Finland Oy Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
CN107105709B (zh) * 2014-10-24 2021-04-30 杜邦营养生物科学有限公司 脯氨酸耐受性三肽基肽酶在饲料添加剂组合物中的用途
EP3172329A1 (en) * 2014-10-24 2017-05-31 Danisco US Inc. Method for producing alcohol by use of a tripeptidyl peptidase
ES2815628T3 (es) 2015-02-20 2021-03-30 Roal Oy Métodos para controlar la producción de proteasas
CN106190874B (zh) * 2015-05-06 2020-06-26 中国科学院天津工业生物技术研究所 一种强化丝状真菌蛋白质生产的方法
CN104990881A (zh) * 2015-07-09 2015-10-21 辽宁省农业科学院蔬菜研究所 一种快速检测羊肚菌菌丝活力的方法
CN108603187A (zh) * 2015-11-24 2018-09-28 诺维信公司 具有蛋白酶活性的多肽以及编码它们的多核苷酸
WO2017101060A1 (en) * 2015-12-17 2017-06-22 Evonik Degussa (China) Co., Ltd. Gene cassette for homologous recombination knock-out in yeast cells
WO2017115005A1 (en) 2015-12-29 2017-07-06 Teknologian Tutkimuskeskus Vtt Oy Production of fusion proteins in trichoderma
KR102593668B1 (ko) 2016-10-04 2023-10-24 다니스코 유에스 인크. 유도 기질 부재 하의 사상 진균 세포에서의 단백질 생산
CN108588060B (zh) 2017-03-07 2020-12-01 武汉康复得生物科技股份有限公司 一种用丝状真菌宿主细胞表达的重组草酸脱羧酶
US11385238B2 (en) * 2017-06-30 2022-07-12 Amgen Inc. Methods of protein clips recovery
US11795487B2 (en) 2017-07-31 2023-10-24 Melt & Marble AB Fungal cell with improved protein production capacity
BR112020003866A2 (pt) 2017-08-30 2020-09-08 Novozymes A/S processo para produção de um produto de fermentação, e, composição.
EP3696274A4 (en) 2017-10-10 2021-07-28 Ajinomoto Co., Inc. PROTEIN MANUFACTURING PROCESS
WO2019175477A1 (en) 2018-03-12 2019-09-19 Teknologian Tutkimuskeskus Vtt Oy A subunit vaccine against porcine post-weaning diarrhoea
US10787656B2 (en) * 2018-05-04 2020-09-29 Fomia BioSolutions, Inc. Variant alkaline protease enzyme compositions and methods
BR112021003459A2 (pt) * 2018-08-29 2021-05-11 Toray Industries, Inc. cepa mutante de trichoderma reesei e métodos para produzir uma proteína, para produzir uma celulase e para produzir um açúcar
CN111088244B (zh) * 2018-10-23 2023-03-21 中国科学院天津工业生物技术研究所 蛋白酶基因在促进纤维素酶生产和复杂氮源利用中的应用
US20220259270A1 (en) * 2019-07-16 2022-08-18 Centro Nacional De Pesquisa Em Energia E Materiais Modified trichoderma fungal strain for the production of an enzyme cocktail
CN110724644A (zh) * 2019-12-05 2020-01-24 西北农林科技大学 一种产重组人胰岛素原的里氏木霉工程菌及其应用
CN115836127A (zh) * 2020-06-11 2023-03-21 味之素株式会社 蛋白的制造方法
EP4189061A1 (en) 2020-07-31 2023-06-07 Biotalys NV Methods of increasing recombinant protein yields
CN113388532B (zh) * 2021-06-16 2023-04-07 华东理工大学 一种用于生产天冬酰胺酶的重组里氏木霉及其构建方法和应用
WO2023003683A2 (en) 2021-07-19 2023-01-26 Danisco Us Inc. Compositions and methods for enhanced protein production in fungal cells
US20250236858A1 (en) 2021-10-15 2025-07-24 Danisco Us Inc. Glucoamylase variants and methods for use thereof
CN118574921A (zh) 2021-12-01 2024-08-30 丹尼斯科美国公司 用于增强真菌细胞中的蛋白质产生的组合物和方法
EP4473119A1 (en) 2022-02-02 2024-12-11 Biotalys NV Modified microbial cells and uses thereof
CN114907992B (zh) * 2022-05-18 2023-06-16 塔里木大学 拮抗植物病原菌的菌株c11及其应用
CN115820692B (zh) * 2022-08-17 2024-05-10 大连理工大学 一种能同时达到去除羊毛虱卵壳与防毡缩的蛋白酶与应用
AU2024271436A1 (en) * 2023-05-15 2025-11-13 Sangamo Therapeutics, Inc. Engineered blood brain barrier penetrant aav capsids
WO2025005761A1 (ko) * 2023-06-29 2025-01-02 씨제이제일제당 (주) 아스파르트산 프로테아제 변이체
WO2025230415A1 (en) 2024-04-30 2025-11-06 Ginkgo Bioworks Netherlands B.V. Host cells expressing optb protein variants and uses thereof

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4758512A (en) 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
CA1333777C (en) 1988-07-01 1995-01-03 Randy M. Berka Aspartic proteinase deficient filamentous fungi
GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
GB2276169A (en) 1990-07-05 1994-09-21 Celltech Ltd Antibodies specific for carcinoembryonic antigen
US5846802A (en) 1992-04-15 1998-12-08 Buxton; Frank Fungal Protease
CA2096289A1 (en) 1992-05-15 1993-11-16 Wouter Musters Cloning and expression of dna encoding a ripening form of a polypeptide having rhamnogalacturonase activity
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
DK52393D0 (enExample) 1993-05-05 1993-05-05 Novo Nordisk As
US5674728A (en) 1993-11-03 1997-10-07 Novartis Corporation Aspergillus niger vacuolar aspartyl protease
ATE256191T1 (de) 1994-06-17 2003-12-15 Novozymes As Ein pilz, in dem das area-gen verändert ist, und ein area-gen aus aspergillus oryzae
US6060305A (en) 1994-06-30 2000-05-09 Novo Nordisk Biotech, Inc. Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system
JPH10508475A (ja) 1994-11-08 1998-08-25 ノボ ノルディスク アクティーゼルスカブ トリペプチジルアミノペプチダーゼ
ATE353953T1 (de) 1995-03-20 2007-03-15 Novozymes As Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion
AU7112796A (en) 1995-09-27 1997-04-17 Chiron Corporation Method of making a protease deficient host
AU1092897A (en) 1995-12-15 1997-07-14 Novo Nordisk A/S A funguns wherein the area, pepc and/or pepe genes have been inactivated
US5776730A (en) 1995-12-15 1998-07-07 University Of Hawaii Neurospora hosts for the production of recombinant proteins, and methods for producing same
EP0877801B1 (en) 1996-01-19 2005-04-27 Novozymes Biotech, Inc. Morphological mutants of filamentous fungi
JP4263241B2 (ja) 1996-03-27 2009-05-13 ノボザイムス アクティーゼルスカブ アルカリプロテアーゼを欠失した糸状真菌
EP0907744A1 (en) 1996-06-05 1999-04-14 Gist-Brocades B.V. Fungal metallo protease genes
ATE313620T1 (de) 1996-09-19 2006-01-15 Novozymes As Wirtszellen und methoden für die produktion von proteinen
US7883872B2 (en) 1996-10-10 2011-02-08 Dyadic International (Usa), Inc. Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
US6806062B1 (en) 1998-10-05 2004-10-19 Novozymes A/S Fungal transcriptional activator useful in methods for producing polypeptides
JP2002535990A (ja) * 1999-02-02 2002-10-29 ノボザイムス バイオテック,インコーポレイティド 真菌細胞においてポリペプチドを生産する方法
CN1195058C (zh) * 1999-02-22 2005-03-30 诺维信公司 草酰乙酸水解酶缺陷型真菌宿主细胞
ATE469223T1 (de) 2000-03-14 2010-06-15 Novozymes As Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden
MXPA01012905A (es) * 2000-04-13 2002-11-22 Mark Aaron Emalfarb Clasificacion de alto rendimiento de bibliotecas de adn expresado en hongo filamentos.
KR20020026456A (ko) 2000-04-13 2002-04-10 에말파브 마크 아론 사상균에서 발현된 dna 라이브러리의 고산출량 스크리닝
WO2002046381A2 (en) 2000-12-07 2002-06-13 Dsm N.V. Method for the prevention or reduction of haze in beverages
AU2002308306B2 (en) 2001-02-23 2007-03-01 Dsm Ip Assets B.V. Genes encoding proteolytic enzymes from aspargilli
WO2003054186A1 (en) 2001-12-21 2003-07-03 Dsm Ip Assets B.V. New rennets
EP1495055B1 (en) 2002-04-18 2013-08-14 Genencor International, Inc. Production of functional antibodies in filamentous fungi
WO2004067709A2 (en) 2003-01-17 2004-08-12 Elitra Pharmaceuticals, Inc. Identification of essential genes of aspergillus fumigatus and methods of use
EP1613761B1 (en) 2003-03-31 2009-09-02 Novozymes Inc. Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger
JP4842834B2 (ja) 2003-12-09 2011-12-21 ノボザイムス,インコーポレイティド 糸状菌株における遺伝子の発現を排除するか又は低めるための方法
GB0405659D0 (en) 2004-03-12 2004-04-21 Horticulture Res Internat Altered expression in filamentous fungi
US7968312B2 (en) 2004-06-16 2011-06-28 Dsm Ip Assets B.V. Production of polypeptides by improved secretion
CN101094919B (zh) 2004-10-12 2014-09-03 帝斯曼知识产权资产管理有限公司 在生产多肽的方法中有用的真菌转录活化因子
GB0424940D0 (en) 2004-11-11 2004-12-15 Danisco Transcription factors
DK1831362T3 (da) 2004-12-30 2012-01-09 Genencor Int Syreaktive svampeproteaser
DK2333045T3 (en) 2005-04-12 2017-02-20 Danisco Us Inc GEN-INACTIVATED MUTANTS WITH CHANGED PROTEIN PRODUCTION
EP2182060B1 (en) 2005-08-03 2012-10-24 Asahi Glass Company, Limited Transformed yeast host cells and method of producing foreign protein
EP1941025B1 (en) * 2005-10-17 2011-06-29 Novozymes A/S Use of fungal mutants for expression of antibodies
WO2007062936A2 (en) 2005-11-29 2007-06-07 Dsm Ip Assets B.V. Dna binding site of a transcriptional activator useful in gene expression
EP2423315B1 (en) 2006-06-29 2015-01-07 DSM IP Assets B.V. A method for achieving improved polypeptide expression
BRPI0716219A2 (pt) 2006-08-29 2013-10-15 Danisco Us Inc Genencor Div Composições e métodos para produção aperfeiçoada de proteína.
US8389269B2 (en) 2006-11-02 2013-03-05 Dsm Ip Assets B.V. Production of secreted proteins by filamentous fungi
US8680252B2 (en) 2006-12-10 2014-03-25 Dyadic International (Usa), Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
US9862956B2 (en) * 2006-12-10 2018-01-09 Danisco Us Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
CN101652479A (zh) 2006-12-21 2010-02-17 诺维信股份有限公司 通过移行rna干扰来降低或消除丝状真菌菌株中的基因表达的方法
EP2508613A3 (en) * 2007-04-03 2012-11-28 Oxyrane UK Limited Glycosylation of molecules
WO2008153712A2 (en) 2007-05-21 2008-12-18 Danisco Us, Inc., Genencor Division Method for introducing nucleic acids into fungal cells
CA2704548A1 (en) * 2007-11-01 2009-05-07 Danisco Us Inc. Signal sequences and co-expressed chaperones for improving protein production in a host cell
US8633010B2 (en) 2007-12-06 2014-01-21 Novozymes A/S Fungal PepC inhibitor
US20090253173A1 (en) 2008-04-08 2009-10-08 Danisco Us Inc., Genencor Division Filamentous fungi with inactivated protease genes for altered protein production
CA2729839A1 (en) 2008-07-03 2010-01-07 Diane Retallack High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein
CN102099466A (zh) 2008-07-29 2011-06-15 丹尼斯科美国公司 在丝状真菌细胞中增加天冬氨酸蛋白酶的产生
CN102227502B (zh) 2008-09-30 2016-01-13 诺维信股份有限公司 在镶片镰孢的酶缺陷突变体中产生多肽的方法
EP2350303A1 (en) * 2008-11-18 2011-08-03 Danisco US Inc. Filamentous fungi with impaired ptrb activity for altered protein production
US9493759B2 (en) 2008-12-12 2016-11-15 Novozymes, Inc. Polypeptides having aspartic endopeptidase activity and polynucleotides encoding same
CA2755417C (en) 2009-03-16 2018-11-13 Dyadic Nederland B.V. New fungal production system
CN104031961A (zh) 2009-10-16 2014-09-10 默沙东公司 生产成熟的人促红细胞生成素的方法以及包含获自该方法的人促红细胞生成素的组合物
US20120213728A1 (en) 2009-10-30 2012-08-23 Merck Granulocyte-colony stimulating factor produced in glycoengineered pichia pastoris
EP2494030A4 (en) 2009-10-30 2013-03-27 Merck Sharp & Dohme METHOD FOR THE PRODUCTION OF THERAPEUTIC PROTEINS IN PICHIA PASTORIS WITHOUT DIPEPTIDYL-AMINOPEPTIDASE ACTIVITY
MX2012004993A (es) 2009-10-30 2012-06-12 Merck Sharp & Dohme Metodos para la produccion de proteinas recombinantes con eficiencias de secrecion mejoradas.
BR112012011980A2 (pt) * 2009-11-19 2021-09-08 Oxyrane Uk Limited Métodos de produzir células transformadas de yarrowia lipolytica e proteínas-alvocompreendendo n-glicanos, células transformadas de yarrowia lipolytica e suas culturas, bem como composição compreendendo glicoproteínas
BR112012013205B1 (pt) 2009-12-18 2020-11-03 Novozymes, Inc. mutante de uma cepa parental de trichoderma reesei, e, métodos para produzir um polipeptídeo de interesse e para obter um mutante de uma cepa parental de trichoderma
AU2010334383B2 (en) 2009-12-21 2014-10-02 Centre Hospitalier Universitaire Vaudois (Chuv) Synergic action of a prolyl protease and tripeptidyl proteases
CN102858949B (zh) 2010-02-24 2016-07-06 默沙东公司 用于增加在巴氏毕赤酵母中生产的治疗性糖蛋白上的n-糖基化位点占据的方法
WO2012021883A2 (en) 2010-08-13 2012-02-16 Dyadic International, Inc. Novel fungal enzymes
WO2012024662A2 (en) 2010-08-20 2012-02-23 Codexis, Inc. Expression constructs comprising fungal promoters
WO2012048334A2 (en) 2010-10-08 2012-04-12 Dyadic International (Usa) Inc. Novel fungal proteases
PL2635671T3 (pl) 2010-11-02 2017-02-28 Codexis, Inc. Ulepszone szczepy grzybowe
IN2014CN02136A (enExample) * 2011-08-24 2015-05-29 Novozymes Inc
BR112014007719A2 (pt) * 2011-09-30 2017-06-13 Codexis Inc proteases fúngicas
BR112014016587A2 (pt) * 2012-01-05 2020-10-27 Novartis Ag células fúngicas filamentosas deficientes de protease e métodos de uso das mesmas
US20150337279A1 (en) 2012-11-20 2015-11-26 Codexis, Inc. Recombinant fungal polypeptides

Also Published As

Publication number Publication date
US20220290165A1 (en) 2022-09-15
JP2015512611A (ja) 2015-04-30
US11180767B2 (en) 2021-11-23
MX355226B (es) 2018-03-23
JP6245528B2 (ja) 2017-12-13
EP3358000A3 (en) 2018-12-19
CA2861697C (en) 2022-03-15
CN107868758A (zh) 2018-04-03
US20190233831A1 (en) 2019-08-01
US20140370546A1 (en) 2014-12-18
WO2013102674A2 (en) 2013-07-11
EP3358000A2 (en) 2018-08-08
JP2018038419A (ja) 2018-03-15
MX2014008272A (es) 2015-02-24
US20210139922A1 (en) 2021-05-13
AU2013207165A1 (en) 2014-07-03
KR20140114860A (ko) 2014-09-29
IL233052A0 (en) 2014-07-31
EP2800809B1 (en) 2018-03-07
BR112014016587A2 (pt) 2020-10-27
EP2800809A2 (en) 2014-11-12
WO2013102674A3 (en) 2013-11-14
US9567596B2 (en) 2017-02-14
US11827891B2 (en) 2023-11-28
RU2014132178A (ru) 2016-02-20
AU2013207165B2 (en) 2018-10-04
RU2645252C2 (ru) 2018-02-19
CA2861697A1 (en) 2013-07-11
US10731168B2 (en) 2020-08-04
CN104245919A (zh) 2014-12-24
US10240159B2 (en) 2019-03-26
CN104245919B (zh) 2017-07-14
SG11201403818XA (en) 2014-08-28
US20170275634A1 (en) 2017-09-28

Similar Documents

Publication Publication Date Title
US11827891B2 (en) Protease deficient filamentous fungal cells and methods of use thereof
US10988791B2 (en) Multiple proteases deficient filamentous fungal cells and methods of use thereof
AU2015293949B2 (en) Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
US20180215797A1 (en) Regulatory Protein Deficient Trichoderma Cells and Methods of Use Thereof
TN et al. gk kkk kMMkkk S kkSkk BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM